Skip to content
Ampicillin
Omnipen-n, Penbritin-s, Polycillin-n, Totacillin-n, Unasyn (ampicillin) is a small molecule pharmaceutical. Ampicillin was first approved as Polycillin-n on 1982-01-01. It is used to treat actinomycosis, bacillary dysentery, bacterial endocarditis, bacterial infections, and bacterial meningitis amongst others in the USA.
Download report
Favorite
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
infectionsD007239
digestive system diseasesD004066
respiratory tract diseasesD012140
nervous system diseasesD009422
urogenital diseasesD000091642
cardiovascular diseasesD002318
skin and connective tissue diseasesD017437
signs and symptoms pathological conditionsD013568
wounds and injuriesD014947
Trade Name
FDA
EMA
Combinations
Unasyn (generic drugs available since 1982-01-01)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Ampicillin sodium
Tradename
Company
Number
Date
Products
POLYCILLIN-NBristol Myers SquibbN-050309 DISCN1982-01-01
5 products
PENBRITIN-SWyethN-050072 DISCN1982-01-01
6 products, RLD
Hide discontinued
Ampicillin sodium
+
Sulbactam sodium
Tradename
Company
Number
Date
Products
UNASYNMylanN-050608 RX1986-12-31
3 products, RLD, RS
Show 1 discontinued
Labels
FDA
EMA
Brand Name
Status
Last Update
ampicillin and sulbactamANDA2023-05-30
unasynNew Drug Application2023-03-29
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
actinomycosisEFO_0007128D000196A42
bacillary dysenteryD004405A03
bacterial endocarditisEFO_1000830D004697
bacterial infectionsD001424A49
bacterial meningitisEFO_1000831D016920G00
bacterial skin diseasesD017192
escherichia coli infectionsEFO_1001318D004927B96.20
gonorrheaDOID_7551D006069A54
haemophilus infectionsEFO_1001127D006192
human bitesD001734W50.3
Show 11 more
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
J: Antiinfectives for systemic use
J01: Antibacterials for systemic use
J01C: Beta-lactam antibacterials, penicillins
J01CA: Penicillins with extended spectrum
J01CA01: Ampicillin
J01CA51: Ampicillin, combinations
J01CR: Combinations of penicillins, incl. beta-lactamase inhibitors
J01CR01: Ampicillin and beta-lactamase inhibitor
S: Sensory organ drugs
S01: Ophthalmologicals
S01A: Antiinfective ophthalmologics
S01AA: Antibiotics, ophthalmologic
S01AA19: Ampicillin
HCPCS
Code
Description
J0290
Injection, ampicillin sodium, 500 mg
J0295
Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm
Clinical
Clinical Trials
99 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
MalariaD008288EFO_0001068B545132622867
Falciparum malariaD016778EFO_0007444B5013615227
AnemiaD000740EFO_0004272D64.92136
MalnutritionD044342EFO_0008572E40-E4611
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Vivax malariaD016780EFO_0007445B51213
FeverD005334HP_0001945R50.9112
PregnancyD011247EFO_0002950Z33.122
Respiratory tract infectionsD012141J06.911
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
PharmacokineticsD010599212
Healthy volunteers/patients212
Covid-19D000086382U07.111
Sickle cell anemiaD000755EFO_0000697D57111
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
HivD006678O98.711
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Hiv infectionsD015658EFO_0000764B2011
SchistosomiasisD012552EFO_1001475B6511
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameAMPICILLIN
INNampicillin
Description
Ampicillin is a penicillin in which the substituent at position 6 of the penam ring is a 2-amino-2-phenylacetamido group. It has a role as an antibacterial drug. It is a penicillin, a penicillin allergen and a beta-lactam antibiotic. It is a conjugate acid of an ampicillin(1-).
Classification
Small molecule
Drug classpenicillins
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccccc3)C(=O)N2[C@H]1C(=O)O
Identifiers
PDB
CAS-ID69-53-4
RxCUI221058
ChEMBL IDCHEMBL174
ChEBI ID28971
PubChem CID6249
DrugBankDB00415
UNII ID7C782967RD (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 159,768 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
32 adverse events reported
View more details